Compare Piramal Healthcare with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs STERLING BIOTECH - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES STERLING BIOTECH PIRAMAL ENTERPRISES/
STERLING BIOTECH
 
P/E (TTM) x 18.7 -0.4 - View Chart
P/BV x 1.2 0.0 8,323.0% View Chart
Dividend Yield % 1.5 0.0 -  

Financials

 PIRAMAL ENTERPRISES   STERLING BIOTECH
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
STERLING BIOTECH
Dec-13
PIRAMAL ENTERPRISES/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs3,30311 31,453.3%   
Low Rs1,7973 52,847.1%   
Sales per share (Unadj.) Rs716.526.8 2,672.7%  
Earnings per share (Unadj.) Rs79.7-15.0 -532.9%  
Cash flow per share (Unadj.) Rs107.9-5.5 -1,975.3%  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.554.9 2,692.2%  
Shares outstanding (eoy) m184.45267.87 68.9%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.60.3 1,372.6%   
Avg P/E ratio x32.0-0.5 -6,884.5%  
P/CF ratio (eoy) x23.6-1.3 -1,857.3%  
Price / Book Value ratio x1.70.1 1,362.7%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,2921,862 25,261.5%   
No. of employees `0007.81.4 577.5%   
Total wages/salary Rs m22,504547 4,115.5%   
Avg. sales/employee Rs Th16,899.45,303.3 318.7%   
Avg. wages/employee Rs Th2,877.7403.8 712.6%   
Avg. net profit/employee Rs Th1,879.9-2,959.0 -63.5%   
INCOME DATA
Net Sales Rs m132,1537,181 1,840.4%  
Other income Rs m3,12843 7,342.7%   
Total revenues Rs m135,2817,223 1,872.8%   
Gross profit Rs m66,290947 7,000.7%  
Depreciation Rs m5,2022,543 204.5%   
Interest Rs m44,0974,377 1,007.5%   
Profit before tax Rs m20,119-5,931 -339.2%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,611-1,924 -447.5%   
Profit after tax Rs m14,701-4,007 -366.9%  
Gross profit margin %50.213.2 380.4%  
Effective tax rate %42.832.4 131.9%   
Net profit margin %11.1-55.8 -19.9%  
BALANCE SHEET DATA
Current assets Rs m122,74214,335 856.2%   
Current liabilities Rs m310,81049,809 624.0%   
Net working cap to sales %-142.3-494.0 28.8%  
Current ratio x0.40.3 137.2%  
Inventory Days Days23403 5.7%  
Debtors Days Days39171 22.8%  
Net fixed assets Rs m116,90455,432 210.9%   
Share capital Rs m369268 137.7%   
"Free" reserves Rs m272,16113,935 1,953.1%   
Net worth Rs m272,53014,701 1,853.8%   
Long term debt Rs m270,1969,478 2,850.8%   
Total assets Rs m856,26173,988 1,157.3%  
Interest coverage x1.5-0.4 -410.3%   
Debt to equity ratio x1.00.6 153.8%  
Sales to assets ratio x0.20.1 159.0%   
Return on assets %6.90.5 1,370.9%  
Return on equity %5.4-27.3 -19.8%  
Return on capital %12.4-6.4 -193.3%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m15,2001,860 817.3%   
Fx outflow Rs m4,88925 19,641.6%   
Net fx Rs m10,3121,835 562.0%   
CASH FLOW
From Operations Rs m-115,9751,719 -6,747.8%  
From Investments Rs m-8,265-3,148 262.5%  
From Financial Activity Rs m107,5251,426 7,540.3%  
Net Cashflow Rs m-16,650-3 489,711.8%  

Share Holding

Indian Promoters % 52.9 33.9 156.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 0.0 -  
FIIs % 26.6 9.9 268.7%  
ADR/GDR % 0.0 16.9 -  
Free float % 16.5 39.3 42.0%  
Shareholders   93,274 21,482 434.2%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   PLETHICO PHARMA  BIOCON   J.B.CHEMICALS  ALKEM LABORATORIES  AJANTA PHARMA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Climbs 975 Points Up; FMCG Stocks Fuel the Rally(09:30 am)

Asian share markets started higher on Monday on hopes of an interim Sino-US tariff deal after the two countries described their talks as "productive" and "constructive".

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Sep 23, 2019 12:15 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS